In this episode of the BtoB Marketing & Sales Podcast I am very proud to welcome Joel Harrison, Editor-in-Chief and co-founder of B2B Marketing.
While I am writing this piece of article, it has been exactly one year since Joel Harrison and I met at the 2017’s BtoB Summit edition in France.
It took me almost a year to dare asking Joel to join me on the BtoB Marketing & Sales podcast, with the view of discussing a very important topic: is there an ideal B2B marketer profile, and if so, what would it be?
Here are the few aspects we are discussing in this podcast episode:
- Are there still tangible differences between B2B and B2C today, besides all we can read on the web on this subject?
- Do young marketing fellows really have the opportunity to become B2B marketer today (scholarship system, accessibility to proper B2B marketing training, etc.)?
- What would be the ideal profile for a B2B marketer?
- Do you need to be an engineer to be the best B2B tech/industry/software marketer?
- Do you even need to study marketing to become a marketer?
- Some big news about B2B Marketing.net.
Connect with Joel:
[This Podcast #7 is also available on iTunes: LISTEN now!]
Joel Harrison is Editor-in-Chief and co-founder of B2B Marketing, the leading provider of insight, best practice and professional development information for business-to-business marketers. Joel launched B2B Marketing as a magazine back in 2004, and has played a key role in its evolution ever since, with the addition of new products and services, and its evolution away from a pure media operation, towards a more holistic and integrated offering (including training, conferences, awards, advisory services, peer-to-peer networking) all focused on helping marketers to be more successful. He currently overseas all B2B Marketing’s content and event activities and is also a regular speaker and passionate evangelist for all things B2B. Joel has spoken at inhouse marketing team meetings for the likes of O2, EY, Fujitsu, PWC, Experian, HPE, Thomson Reuters, Barnett Waddingham, Accenture, Oliver Wyman and Syngenta.